Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

10.7%

19 terminated/withdrawn out of 177 trials

Success Rate

80.2%

-6.4% vs industry average

Late-Stage Pipeline

14%

24 trials in Phase 3/4

Results Transparency

12%

9 of 77 completed trials have results

Key Signals

30 recruiting9 with results18 terminated

Enrollment Performance

Analytics

N/A
59(41.0%)
Phase 2
42(29.2%)
Phase 3
22(15.3%)
Phase 1
19(13.2%)
Phase 4
2(1.4%)
144Total
N/A(59)
Phase 2(42)
Phase 3(22)
Phase 1(19)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (177)

Showing 20 of 177 trials
NCT07853105Phase 1Not Yet Recruiting

Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.

Role: collaborator

NCT05607849Not ApplicableCompleted

Breast Cancer Screening Uptake: a Randomized Controlled Trial Assessing the Effect of a Decisional Aid

Role: collaborator

NCT02598219Phase 3Completed

Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence.

Role: collaborator

NCT07243470Phase 1Recruiting

Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

Role: collaborator

NCT05821231Phase 1Completed

Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma

Role: collaborator

NCT04222335Not ApplicableCompleted

Understanding and Overcoming the Early Adaptive Resistance to EGFR Tyrosine-kinase Inhibitors in Lung Cancer Patients

Role: collaborator

NCT00433706Phase 3Completed

Image Guided Radiation Therapy For Prostate Cancer

Role: collaborator

NCT02515877Phase 1Completed

Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers

Role: collaborator

NCT04007640Not ApplicableTerminated

Early Screening of Pancreatic Lesions : Development of New Imaging Tools

Role: collaborator

NCT04899492Not ApplicableTerminated

Evaluating Smoking Cessation Protocols in Cancer Patients: NRT, MI, CBT or Hypnotherapy

Role: collaborator

NCT03077776Not ApplicableActive Not Recruiting

Tracking Triple-negative Breast Cancer Evolution Through Therapy

Role: collaborator

NCT04747054Phase 3Recruiting

Study on the Efficacy of Treatment by Radiotherapy and Pembrolizumab in Newly Diagnosed Metastatic Head & Neck Cancers

Role: collaborator

NCT02029001Phase 2Recruiting

Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

Role: collaborator

NCT03915678Phase 2Active Not Recruiting

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

Role: collaborator

NCT07241273Not ApplicableNot Yet Recruiting

SPECT-CT Guided ELEctive Contralateral Neck Treatment in Lateralized Oropharyngeal Cancer

Role: collaborator

NCT02813135Phase 1Recruiting

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Role: collaborator

NCT04213365Not ApplicableCompleted

Management of Cognitive Difficulties After Cancer Treatments in Women Treated for Breast Cancer: Feasibility Study (Step 1 of the Cog-Stim Protocol)

Role: collaborator

NCT02724163Phase 3Active Not Recruiting

International Randomised Phase III Clinical Trial in Children With Acute Myeloid Leukaemia

Role: collaborator

NCT07594990Not Yet Recruiting

The MAI-FOIE Cohort

Role: collaborator

NCT05180695Phase 1Active Not Recruiting

HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas

Role: collaborator